scispace - formally typeset
Search or ask a question
Journal ArticleDOI

Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults: Implications for Primary Prevention.

TL;DR: The genomic score developed and evaluated here substantially advances the concept of using genomic information to stratify individuals with different trajectories of CAD risk and highlights the potential for genomic screening in early life to complement conventional risk prediction.
About: This article is published in Journal of the American College of Cardiology.The article was published on 2018-10-16 and is currently open access. It has received 522 citations till now. The article focuses on the topics: Framingham Risk Score.
Citations
More filters
Journal ArticleDOI
TL;DR: This year's edition of the Statistical Update includes data on the monitoring and benefits of cardiovascular health in the population, metrics to assess and monitor healthy diets, an enhanced focus on social determinants of health, a focus on the global burden of cardiovascular disease, and further evidence-based approaches to changing behaviors, implementation strategies, and implications of the American Heart Association’s 2020 Impact Goals.
Abstract: Background: The American Heart Association, in conjunction with the National Institutes of Health, annually reports on the most up-to-date statistics related to heart disease, stroke, and cardiovas...

5,078 citations

Journal ArticleDOI
TL;DR: In this article, the authors present guidelines for the management of patients with coronary artery disease (CAD), which is a pathological process characterized by atherosclerotic plaque accumulation in the epicardial arteries.
Abstract: Coronary artery disease (CAD) is a pathological process characterized by atherosclerotic plaque accumulation in the epicardial arteries, whether obstructive or non-obstructive. This process can be modified by lifestyle adjustments, pharmacological therapies, and invasive interventions designed to achieve disease stabilization or regression. The disease can have long, stable periods but can also become unstable at any time, typically due to an acute atherothrombotic event caused by plaque rupture or erosion. However, the disease is chronic, most often progressive, and hence serious, even in clinically apparently silent periods. The dynamic nature of the CAD process results in various clinical presentations, which can be conveniently categorized as either acute coronary syndromes (ACS) or chronic coronary syndromes (CCS). The Guidelines presented here refer to the management of patients with CCS. The natural history of CCS is illustrated in Figure 1.

3,448 citations

Journal ArticleDOI
TL;DR: The American Heart Association, in conjunction with the National Institutes of Health, annually reports the most up-to-date statistics related to heart disease, stroke, and cardiovascul...
Abstract: Background: The American Heart Association, in conjunction with the National Institutes of Health, annually reports the most up-to-date statistics related to heart disease, stroke, and cardiovascul...

3,034 citations

Journal ArticleDOI
Frank L.J. Visseren, François Mach, Yvo M. Smulders, David Carballo, Konstantinos C. Koskinas, Maria Bäck, Athanase Benetos, Alessandro Biffi, José-Manuel Boavida1, Davide Capodanno, Bernard Cosyns, Carolyn Crawford, Constantinos H. Davos, Ileana Desormais, Emanuele Di Angelantonio, Oscar H. Franco, Sigrun Halvorsen, FD Richard Hobbs, Monika Hollander, Ewa A. Jankowska, Matthias Michal, Simona Sacco, Naveed Sattar, Lale Tokgozoglu, Serena Tonstad, Konstantinos P Tsioufis2, Ineke van Dis, Isabelle C. Van Gelder, Christoph Wanner3, Bryan Williams, Guy De Backer, Vera Regitz-Zagrosek, Anne Hege Aamodt, Magdy Abdelhamid, Victor Aboyans, Christian Albus, Riccardo Asteggiano, Magnus Bäck, Michael A. Borger, Carlos Brotons, Jelena Čelutkienė, Renata Cifkova, Maja Čikeš, Francesco Cosentino, Nikolaos Dagres, Tine De Backer, Dirk De Bacquer, Victoria Delgado, Hester Den Ruijter, Paul Dendale, Heinz Drexel, Volkmar Falk, Laurent Fauchier, Brian A. Ference, Jean Ferrières, Marc Ferrini4, Miles Fisher4, Danilo Fliser3, Zlatko Fras, Dan Gaita, Simona Giampaoli, Stephan Gielen, Ian D. Graham, Catriona Jennings, Torben Jørgensen, Alexandra Kautzky-Willer, Maryam Kavousi, Wolfgang Koenig, Aleksandra Konradi, Dipak Kotecha, Ulf Landmesser, Madalena Lettino, Basil S. Lewis, Aleš Linhart, Maja-Lisa Løchen1, Konstantinos Makrilakis1, Giuseppe Mancia2, Pedro Marques-Vidal, John W. McEvoy, Paul McGreavy, Béla Merkely, Lis Neubeck, Jens Cosedis Nielsen, Joep Perk, Steffen E. Petersen, Anna Sonia Petronio, Massimo F Piepoli, Nana Pogosova, Eva Prescott, Kausik K. Ray, Zeljko Reiner, Dimitrios J. Richter, Lars Rydén, Evgeny Shlyakhto, Marta Sitges, Miguel Sousa-Uva, Isabella Sudano, Monica Tiberi, Rhian M. Touyz, Andrea Ungar, W. M. Monique Verschuren, Olov Wiklund, David A. Wood, José Luis Zamorano, Carolyn A Crawford, Oscar H Franco Duran 

1,650 citations

Journal ArticleDOI
TL;DR: The American Heart Association, through its Statistics Committee, continuously monitors and evaluates sources of data on heart disease and stroke in the United States to provide the most current information available in the annual Statistical Update as discussed by the authors .
Abstract: The American Heart Association, in conjunction with the National Institutes of Health, annually reports the most up-to-date statistics related to heart disease, stroke, and cardiovascular risk factors, including core health behaviors (smoking, physical activity, diet, and weight) and health factors (cholesterol, blood pressure, and glucose control) that contribute to cardiovascular health. The Statistical Update presents the latest data on a range of major clinical heart and circulatory disease conditions (including stroke, congenital heart disease, rhythm disorders, subclinical atherosclerosis, coronary heart disease, heart failure, valvular disease, venous disease, and peripheral artery disease) and the associated outcomes (including quality of care, procedures, and economic costs).The American Heart Association, through its Statistics Committee, continuously monitors and evaluates sources of data on heart disease and stroke in the United States to provide the most current information available in the annual Statistical Update. The 2022 Statistical Update is the product of a full year's worth of effort by dedicated volunteer clinicians and scientists, committed government professionals, and American Heart Association staff members. This year's edition includes data on the monitoring and benefits of cardiovascular health in the population and an enhanced focus on social determinants of health, adverse pregnancy outcomes, vascular contributions to brain health, and the global burden of cardiovascular disease and healthy life expectancy.Each of the chapters in the Statistical Update focuses on a different topic related to heart disease and stroke statistics.The Statistical Update represents a critical resource for the lay public, policymakers, media professionals, clinicians, health care administrators, researchers, health advocates, and others seeking the best available data on these factors and conditions.

1,483 citations

References
More filters
Journal ArticleDOI
TL;DR: The UK Biobank is described, a large population-based prospective study, established to allow investigation of the genetic and non-genetic determinants of the diseases of middle and old age.
Abstract: Cathie Sudlow and colleagues describe the UK Biobank, a large population-based prospective study, established to allow investigation of the genetic and non-genetic determinants of the diseases of middle and old age.

6,114 citations


"Genomic Risk Prediction of Coronary..." refers background or methods in this paper

  • ...We utilized a metaanalytic strategy to construct a GRS for CAD (metaGRS) that captures the totality of information from the largest previous genome-wide association studies, and then investigated the external performance of this metaGRS in stratifying CAD risk in >480,000 individuals from the UK Biobank (UKB) (15)....

    [...]

  • ...Details of the design of the UKB have been reported previously (15)....

    [...]

Journal ArticleDOI
TL;DR: UNLABELLED ROCR is a package for evaluating and visualizing the performance of scoring classifiers in the statistical language R that features over 25 performance measures that can be freely combined to create two-dimensional performance curves.
Abstract: Summary: ROCR is a package for evaluating and visualizing the performance of scoring classifiers in the statistical language R. It features over 25 performance measures that can be freely combined to create two-dimensional performance curves. Standard methods for investigating trade-offs between specific performance measures are available within a uniform framework, including receiver operating characteristic (ROC) graphs, precision/recall plots, lift charts and cost curves. ROCR integrates tightly with R's powerful graphics capabilities, thus allowing for highly adjustable plots. Being equipped with only three commands and reasonable default values for optional parameters, ROCR combines flexibility with ease of usage. Availability:http://rocr.bioinf.mpi-sb.mpg.de. ROCR can be used under the terms of the GNU General Public License. Running within R, it is platform-independent. Contact: tobias.sing@mpi-sb.mpg.de

2,838 citations


"Genomic Risk Prediction of Coronary..." refers methods in this paper

  • ...Sing T, Sander O, Beerenwinkel N, Lengauer T. ROCR: visualizing classifier performance in R. Bioinformatics 2005;21:3940–1....

    [...]

  • ...The precision-recall curves (equivalent to the positivepredictive-value vs sensitivity curve) were computed in the R package “ROCR” (20), and the area under the curve was computed using numerical integration....

    [...]

Journal ArticleDOI
Shane A. McCarthy1, Sayantan Das2, Warren W. Kretzschmar3, Olivier Delaneau4, Andrew R. Wood5, Alexander Teumer6, Hyun Min Kang2, Christian Fuchsberger2, Petr Danecek1, Kevin Sharp3, Yang Luo1, C Sidore7, Alan Kwong2, Nicholas J. Timpson8, Seppo Koskinen, Scott I. Vrieze9, Laura J. Scott2, He Zhang2, Anubha Mahajan3, Jan H. Veldink, Ulrike Peters10, Ulrike Peters11, Carlos N. Pato12, Cornelia M. van Duijn13, Christopher E. Gillies2, Ilaria Gandin14, Massimo Mezzavilla, Arthur Gilly1, Massimiliano Cocca14, Michela Traglia, Andrea Angius7, Jeffrey C. Barrett1, D.I. Boomsma15, Kari Branham2, Gerome Breen16, Gerome Breen17, Chad M. Brummett2, Fabio Busonero7, Harry Campbell18, Andrew T. Chan19, Sai Chen2, Emily Y. Chew20, Francis S. Collins20, Laura J Corbin8, George Davey Smith8, George Dedoussis21, Marcus Dörr6, Aliki-Eleni Farmaki21, Luigi Ferrucci20, Lukas Forer22, Ross M. Fraser2, Stacey Gabriel23, Shawn Levy, Leif Groop24, Leif Groop25, Tabitha A. Harrison11, Andrew T. Hattersley5, Oddgeir L. Holmen26, Kristian Hveem26, Matthias Kretzler2, James Lee27, Matt McGue28, Thomas Meitinger29, David Melzer5, Josine L. Min8, Karen L. Mohlke30, John B. Vincent31, Matthias Nauck6, Deborah A. Nickerson10, Aarno Palotie23, Aarno Palotie19, Michele T. Pato12, Nicola Pirastu14, Melvin G. McInnis2, J. Brent Richards32, J. Brent Richards16, Cinzia Sala, Veikko Salomaa, David Schlessinger20, Sebastian Schoenherr22, P. Eline Slagboom33, Kerrin S. Small16, Tim D. Spector16, Dwight Stambolian34, Marcus A. Tuke5, Jaakko Tuomilehto, Leonard H. van den Berg, Wouter van Rheenen, Uwe Völker6, Cisca Wijmenga35, Daniela Toniolo, Eleftheria Zeggini1, Paolo Gasparini14, Matthew G. Sampson2, James F. Wilson18, Timothy M. Frayling5, Paul I.W. de Bakker36, Morris A. Swertz35, Steven A. McCarroll19, Charles Kooperberg11, Annelot M. Dekker, David Altshuler, Cristen J. Willer2, William G. Iacono28, Samuli Ripatti25, Nicole Soranzo1, Nicole Soranzo27, Klaudia Walter1, Anand Swaroop20, Francesco Cucca7, Carl A. Anderson1, Richard M. Myers, Michael Boehnke2, Mark I. McCarthy3, Mark I. McCarthy37, Richard Durbin1, Gonçalo R. Abecasis2, Jonathan Marchini3 
TL;DR: A reference panel of 64,976 human haplotypes at 39,235,157 SNPs constructed using whole-genome sequence data from 20 studies of predominantly European ancestry leads to accurate genotype imputation at minor allele frequencies as low as 0.1% and a large increase in the number of SNPs tested in association studies.
Abstract: We describe a reference panel of 64,976 human haplotypes at 39,235,157 SNPs constructed using whole-genome sequence data from 20 studies of predominantly European ancestry. Using this resource leads to accurate genotype imputation at minor allele frequencies as low as 0.1% and a large increase in the number of SNPs tested in association studies, and it can help to discover and refine causal loci. We describe remote server resources that allow researchers to carry out imputation and phasing consistently and efficiently.

2,149 citations

Journal ArticleDOI
TL;DR: UK Biobank is not representative of the sampling population; there is evidence of a “healthy volunteer” selection bias; valid assessment of exposure-disease relationships may be widely generalizable and does not require participants to be Representative of the population at large.
Abstract: The UK Biobank cohort is a population-based cohort of 500,000 participants recruited in the United Kingdom (UK) between 2006 and 2010. Approximately 9.2 million individuals aged 40-69 years who lived within 25 miles (40 km) of one of 22 assessment centers in England, Wales, and Scotland were invited to enter the cohort, and 5.5% participated in the baseline assessment. The representativeness of the UK Biobank cohort was investigated by comparing demographic characteristics between nonresponders and responders. Sociodemographic, physical, lifestyle, and health-related characteristics of the cohort were compared with nationally representative data sources. UK Biobank participants were more likely to be older, to be female, and to live in less socioeconomically deprived areas than nonparticipants. Compared with the general population, participants were less likely to be obese, to smoke, and to drink alcohol on a daily basis and had fewer self-reported health conditions. At age 70-74 years, rates of all-cause mortality and total cancer incidence were 46.2% and 11.8% lower, respectively, in men and 55.5% and 18.1% lower, respectively, in women than in the general population of the same age. UK Biobank is not representative of the sampling population; there is evidence of a "healthy volunteer" selection bias. Nonetheless, valid assessment of exposure-disease relationships may be widely generalizable and does not require participants to be representative of the population at large.

1,896 citations

Journal ArticleDOI
Majid Nikpay1, Anuj Goel2, Won H-H.3, Leanne M. Hall4  +164 moreInstitutions (60)
TL;DR: This article conducted a meta-analysis of coronary artery disease (CAD) cases and controls, interrogating 6.7 million common (minor allele frequency (MAF) > 0.05) and 2.7 millions low-frequency (0.005 < MAF < 0.5) variants.
Abstract: Existing knowledge of genetic variants affecting risk of coronary artery disease (CAD) is largely based on genome-wide association study (GWAS) analysis of common SNPs. Leveraging phased haplotypes from the 1000 Genomes Project, we report a GWAS meta-analysis of ∼185,000 CAD cases and controls, interrogating 6.7 million common (minor allele frequency (MAF) > 0.05) and 2.7 million low-frequency (0.005 < MAF < 0.05) variants. In addition to confirming most known CAD-associated loci, we identified ten new loci (eight additive and two recessive) that contain candidate causal genes newly implicating biological processes in vessel walls. We observed intralocus allelic heterogeneity but little evidence of low-frequency variants with larger effects and no evidence of synthetic association. Our analysis provides a comprehensive survey of the fine genetic architecture of CAD, showing that genetic susceptibility to this common disease is largely determined by common SNPs of small effect size.

1,839 citations